Positioning blinatumomab in the frontline of adult B-cell acute lymphoblastic leukemia treatment
H Pourhassan, V Agrawal, V Pullarkat… - Frontiers in oncology, 2023 - frontiersin.org
Blinatumomab is a bispecific T cell engager that has shown efficacy in relapsed/refractory
Philadelphia chromosome (Ph)-positive and Ph-negative acute lymphoblastic leukemia …
Philadelphia chromosome (Ph)-positive and Ph-negative acute lymphoblastic leukemia …
Philadelphia-like acute lymphoblastic leukemia: the journey from molecular background to the role of bone marrow transplant
Philadelphia chromosome-like (Ph-like) ALL is a recent subtype of acute lymphoblastic
leukemia. Although it does not express the BCR-ABL fusion gene, it has a behavior like true …
leukemia. Although it does not express the BCR-ABL fusion gene, it has a behavior like true …
Predicting relapse in acute lymphoblastic leukemia
MS Schwartz, LS Muffly - Leukemia & Lymphoma, 2024 - Taylor & Francis
Outcomes in adult and pediatric patients with acute lymphoblastic leukemia (ALL) have
improved over successive generations due to rigorously conducted clinical trials and …
improved over successive generations due to rigorously conducted clinical trials and …